Kessler L, Schwaning F, Metzenmacher M, Pabst K, et al. Fibroblast Activation Protein-Directed Imaging Outperforms (18)F-FDG PET/CT in Malignant Mesothelioma: A Prospective, Single-Center, Observational Trial. J Nucl Med 2024 Jul 3:jnumed.124.267473. doi: 10.2967/jnumed.124.267473.
PMID: 38960716